Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

CEACAM1 and MICA as novel serum biomarkers in patients with acute and recurrent pericarditis.

Markel G, Imazio M, Koren-Morag N, Galore-Haskel G, Schachter J, Besser M, Cumetti D, Maestroni S, Altman A, Shoenfeld Y, Brucato A, Adler Y.

Oncotarget. 2016 Apr 5;7(14):17885-95. doi: 10.18632/oncotarget.7530.

2.

γδ T Cells Protect the Liver and Lungs of Mice from Autoimmunity Induced by Scurfy Lymphocytes.

Ujiie H, Shevach EM.

J Immunol. 2016 Feb 15;196(4):1517-28. doi: 10.4049/jimmunol.1501774. Epub 2016 Jan 15.

PMID:
26773142
3.

NKG2D and its ligands: active factors in the outcome of solid organ transplantation?

Suárez-Álvarez B, Fernández-Sánchez A, López-Vázquez A, Coto E, Ortega F, López-Larrea C.

Kidney Int Suppl (2011). 2011 Aug;1(2):52-57.

4.

Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis.

Weinger JG, Plaisted WC, Maciejewski SM, Lanier LL, Walsh CM, Lane TE.

Stem Cells. 2014 Oct;32(10):2690-701. doi: 10.1002/stem.1760.

5.

Effector mechanisms of rejection.

Moreau A, Varey E, Anegon I, Cuturi MC.

Cold Spring Harb Perspect Med. 2013 Nov 1;3(11). pii: a015461. doi: 10.1101/cshperspect.a015461. Review.

6.

Natural killer cell-activating receptor NKG2D mediates innate immune targeting of allogeneic neural progenitor cell grafts.

Phillips LK, Gould EA, Babu H, Krams SM, Palmer TD, Martinez OM.

Stem Cells. 2013 Sep;31(9):1829-39. doi: 10.1002/stem.1422.

7.

NKG2D blockade attenuated cardiac allograft vasculopathy in a mouse model of cardiac transplantation.

Chen H, Xia J, Zhang L, Jin X, Yang M, Li J, Zhao Y.

Clin Exp Immunol. 2013 Sep;173(3):544-52. doi: 10.1111/cei.12128.

8.

NKG2D blockade inhibits poly(I:C)-triggered fetal loss in wild type but not in IL-10-/- mice.

Thaxton JE, Nevers T, Lippe EO, Blois SM, Saito S, Sharma S.

J Immunol. 2013 Apr 1;190(7):3639-47. doi: 10.4049/jimmunol.1203488. Epub 2013 Mar 1.

9.

Innate immunity and resistance to tolerogenesis in allotransplantation.

Benichou G, Tonsho M, Tocco G, Nadazdin O, Madsen JC.

Front Immunol. 2012 Apr 19;3:73. doi: 10.3389/fimmu.2012.00073. eCollection 2012.

10.

Pharmacological Evaluation of the SCID T Cell Transfer Model of Colitis: As a Model of Crohn's Disease.

Lindebo Holm T, Poulsen SS, Markholst H, Reedtz-Runge S.

Int J Inflam. 2012;2012:412178. doi: 10.1155/2012/412178. Epub 2012 Feb 19.

11.

Changes in natural killer cell subsets in pediatric liver transplant recipients.

Pham B, Piard-Ruster K, Silva R, Gallo A, Esquivel CO, Martinez OM, Krams SM.

Pediatr Transplant. 2012 Mar;16(2):176-82. doi: 10.1111/j.1399-3046.2012.01653.x.

12.

γδ T cells augment rejection of skin grafts by enhancing cross-priming of CD8 T cells to skin-derived antigen.

Rahimpour A, Mattarollo SR, Yong M, Leggatt GR, Steptoe RJ, Frazer IH.

J Invest Dermatol. 2012 Jun;132(6):1656-64. doi: 10.1038/jid.2012.16. Epub 2012 Feb 23.

13.

Primary vascularization of the graft determines the immunodominance of murine minor H antigens during organ transplantation.

Kwun J, Malarkannan S, Burlingham WJ, Knechtle SJ.

J Immunol. 2011 Oct 15;187(8):3997-4006. doi: 10.4049/jimmunol.1003918. Epub 2011 Sep 7.

14.

The innate immune system in transplantation.

Oberbarnscheidt MH, Zecher D, Lakkis FG.

Semin Immunol. 2011 Aug;23(4):264-72. doi: 10.1016/j.smim.2011.06.006. Epub 2011 Jul 1. Review.

15.

The SCHOOL of nature: III. From mechanistic understanding to novel therapies.

Sigalov AB.

Self Nonself. 2010 Jul;1(3):192-224. Epub 2010 Jun 11.

16.

Natural killer cells in rejection and tolerance of solid organ allografts.

Benichou G, Yamada Y, Aoyama A, Madsen JC.

Curr Opin Organ Transplant. 2011 Feb;16(1):47-53. doi: 10.1097/MOT.0b013e32834254cf. Review.

17.

Innate immunity and cardiac allograft rejection.

Millington TM, Madsen JC.

Kidney Int Suppl. 2010 Dec;(119):S18-21. doi: 10.1038/ki.2010.417. Review.

18.

Identification of the rat NKG2D ligands, RAE1L and RRLT, and their role in allograft rejection.

Zhuo M, Fujiki M, Wang M, Piard-Ruster K, Wai LE, Wei L, Martinez OM, Krams SM.

Eur J Immunol. 2010 Jun;40(6):1748-57. doi: 10.1002/eji.200939779.

19.

NK cell patrolling and elimination of donor-derived dendritic cells favor indirect alloreactivity.

Garrod KR, Liu FC, Forrest LE, Parker I, Kang SM, Cahalan MD.

J Immunol. 2010 Mar 1;184(5):2329-36. doi: 10.4049/jimmunol.0902748. Epub 2010 Feb 5.

20.

Innate immunity in heart transplantation.

Millington TM, Madsen JC.

Curr Opin Organ Transplant. 2009 Oct;14(5):571-6. doi: 10.1097/MOT.0b013e32832e7158. Review.

Items per page

Supplemental Content

Write to the Help Desk